UPDATE 2-AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer By: Reuters: Company News December 30, 2019 at 04:28 AM EST * First of its kind to get FDA okay to treat pancreatic cancer Read More >> Related Stocks: Astrazeneca Plc ADR Clovis Oncology Inc Gsk Plc ADR Merck & Co Pfizer